Nearly 70 players from across the world presently claim to be engaged in the development and evaluation of therapeutic candidates based on a number of psychedelic compounds, such as ketamine and psilocybin, claims Roots Analysis

Close to 130 industry and non-industry players, across the globe, claim to have the necessary expertise and supporting infrastructure to manufacture a wide variety of radioisotopes, for in-house use, or as a contract service, claims Roots Analysis

Presently, over 65 companies claim to offer drug repurposing-related services to the global pharmaceutical industry; interestingly, the majority (>55%) of such service providers firms are based in Europe, claims Roots Analysis

Presently, more than 120 companies claim to offer AR / VR and affiliated digital marketing services to the global healthcare industry, claims Roots Analysis

Over 100 industry players are engaged in evaluating the potential of several prescription (validated through clinical research) digital therapeutic solutions to prevent / treat various chronic diseases

Over 80 firms are involved in providing antibody drug discovery-related services; whereas close to 125 players are offering antibody discovery platforms

Global Psychedelic Therapeutics Market is projected to grow at an annualized rate of ~15%, till 2030

The Nuclear Medicine and Radiopharmaceuticals Manufacturing Market is projected to grow at an annualized rate of over 10%, till 2030

The Drug Repurposing Service Providers Market is projected to grow at an annualized rate of 14.7%, till 2030

The Market Opportunity for AR / VR based Healthcare Digital Marketing Service Providers is likely to grow at a CAGR of 26%, till 2030

The Global Digital Therapeutics Market is projected to be worth over USD 8.8 billion by 2030, predicts Roots Analysis

The Antibody Discovery Services Market is estimated to be worth around USD 6.5 billion by 2030 instead the antibody discovery platforms market is anticipated to be worth close to USD 6 billion by 2030, predicts Roots Analysis

Global Psychedelic Therapeutics Market is estimated to be worth over USD 6.5 billion in 2030, predicts Roots Analysis

The Nuclear Medicine and Radiopharmaceutical Manufacturing Market is estimated to be more than USD 6 billion in 2030, predicts Roots Analysis

Drugrepurposing enables drug developers to optimize on past efforts andexpenditure, thereby, offering a viable life cycle management strategy formarketed products and opportunities to re-evaluate failed / shelved drugdevelopment programs